Search
+
    SEARCHED FOR:

    JNK INDIA IPO SUBSCRIPTION

    Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?

    Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.

    Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details

    Bansal Wire's IPO has been nearly 4 times oversubscribed on its second day, fueled by robust demand from non-institutional and retail investors. The IPO, conducted through the book-building method, reserves 50% for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional investors.

    Bansal Wire IPO sails through on Day 1 on robust NII, retail demand. Check GMP and other details

    Bansal Wire's IPO saw strong demand from retail and non-institutional investors on the first day, while the QIB portion remained unsubscribed. Proceeds will be used for debt repayment, working capital, and general corporate purposes.

    Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors

    Emcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO price band, raising Rs 582.6 crore. The public subscription for the IPO will commence on July 3rd and conclude on July 5th.

    Bansal Wire IPO to open for subscription on Wednesday. Here's what GMP indicates

    The company aims to raise approximately Rs 745 crore at the upper end of its price band. Investors can bid for a minimum of 58 shares per lot, with the option to bid in multiples of this lot size. Prior to the IPO subscription, the company's shares were trading at a premium of Rs 65 in the unlisted market.

    Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription

    Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.

    The Economic Times
    BACK TO TOP